Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-40.27	93.50	156.54
Graham Fair Price	2.08	0.88	0.87
PEG	2192.82	13.10	-0.57
Price/Book	-19.97	3.35	4.19
Price/Cash Flow	-37.81	106.54	-171.31
Prices/Earnings	-24.08	64.84	85.40
Price/Sales	-16.59	17.43	20.89
Price/FCF	-37.81	106.54	-171.31
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	37.77	0.29	0.21
Operating Margin	9.01	0.15	0.14
ROA	7.87	< 0.005	< 0.005
ROE	0.01	0.01	5.41
ROIC	0.01	0.01	17.94
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.15	-0.02	-602.95
Dividends QOQ	-0.53	2.47	365.97
EBIT QOQ	1.35	0.04	-97.05
EPS QOQ	1.50	0.05	-96.69
FCF QOQ	-1.24	2.28	83.66
Revenue QOQ	-0.07	-0.05	32.46
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	455.58	536.56	17.77
Days Sales Outstanding (DSO)	100.30	108.04	7.71
Inventory Turnover	0.20	0.17	-15.09
Debt/Capitalization	0.29	0.30	0.43
Quick Ratio	0.80	0.81	1.93
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.65	2.04	23.59
Cash	0.99	0.85	-14.14
Capex	< 0.005	0.01	48.98
Free Cash Flow	-0.04	0.05	27.93
Revenue	0.33	0.32	-4.61
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.61	1.66	3.26
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.20	-2.21	-83.76
Naive Interpretation	Member

06 - Financial Health · Weak

Rating